Current Pharmaceutical Design

Show Articles
Journal Properties
  • Country
    United Arab Emirates
  • Language
    English
  • Number of Articles
    10,576
  • Abbreviation
    Curr Pharm Des
  • ISSN
    1381-6128
  • Main Publisher
    Bentham Science Publishers
  • Publisher
    Bentham Science Publishers Ltd.
  • Indian UGC
  • Indian UGC Name
  • DOAJ (latest)
Journal Properties
  • Medicine
    Public aspects of medicine
    Toxicology
    Poisons
    Medicine
    Therapeutics
    Pharmacology
  • website
Description
Current Pharmaceutical Design offers comprehensive reviews on cutting-edge topics in drug design and discovery. It provides in-depth coverage of current advances in medicinal chemistry, pharmacology, and rational drug design. The journal emphasizes structure-activity relationships, molecular modeling, and the therapeutic potential of novel chemical entities. This journal focuses on a broad range of subjects, including reviews on computer-aided drug design, drug targets, and clinical studies. Indexed in CAS, Scopus, and Web of Science, it serves as a vital resource for researchers in academia and pharmaceutical industries. Current Pharmaceutical Design delivers timely insights for professionals seeking to develop innovative therapeutic agents. Submissions are welcomed from researchers worldwide who aim to contribute significantly to the field of drug design. By publishing in this journal, authors gain valuable exposure for their work. It may even help promote collaborations within the pharmaceutical research community, as well as speeding up progress in the development of new and improved medicines.